Brady Richard R W, Scott Julia, Grieveson Stephanie, Aibibula Miriayi, Cawson Matthew, Marks Tatjana, Page Jennifer, Artignan Audrey, Boisen Esben Bo
Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.
Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.
J Wound Ostomy Continence Nurs. 2023;50(6):475-483. doi: 10.1097/WON.0000000000001028.
The purpose of this study was to evaluate clinical and economic outcomes during the first year following ostomy formation.
Single-center retrospective audit.
The sample comprised 200 patients who underwent surgery leading to ileostomy or colostomy at a large English National Health Service (NHS) Trust.
Clinical complications, medicine prescriptions, and interactions with healthcare services were reported over 12 months postsurgery, and interactions with the NHS were matched to the closest NHS unit cost to determine mean patient cost.
The most common ostomy-related surgical site complications were high output (35.0%; n = 70), followed by moderate/severe peristomal skin complications (24.5%; n = 49) and bleeding (23.5%; n = 47). Ostomy management-related complications included general difficulties with ostomy management (50.0%; n = 100) and leakage-related mild peristomal skin issues (48.5%; n = 97). Clinical complication rates were highest in the first quarter following ostomy formation, except parastomal hernia, which increased in incidence over time. Ileostomy patients more frequently experienced high output, acute renal failure, and ostomy management-related complications and had increased length of inpatient admission. However, healthcare resource use was high in both groups, with a median of 13 inpatient admission days and 12 outpatient contacts overall within the first year. Mean cost per patient was £20,444.60 (US $26,018.41); 90.5% of these costs were attributed to ostomy-related factors.
Patients are likely to experience at least one clinical complication following intestinal ostomy formation and have multiple interactions with the NHS. While a number of complications are more frequent in patients with ileostomies, both groups experienced considerable costs within the first year following surgery associated with ostomy management and recovery.
本研究旨在评估造口形成后第一年的临床和经济结果。
单中心回顾性审计。
样本包括200例在英国一家大型国民健康服务(NHS)信托机构接受导致回肠造口术或结肠造口术手术的患者。
报告术后12个月内的临床并发症、药物处方以及与医疗服务的互动情况,并将与NHS的互动情况与最接近的NHS单位成本相匹配,以确定患者的平均成本。
最常见的与造口相关的手术部位并发症是高排出量(35.0%;n = 70),其次是中度/重度造口周围皮肤并发症(24.5%;n = 49)和出血(23.5%;n = 47)。与造口管理相关的并发症包括造口管理的一般困难(50.0%;n = 100)和与渗漏相关的轻度造口周围皮肤问题(48.5%;n = 97)。除造口旁疝外,造口形成后第一季度临床并发症发生率最高,造口旁疝的发生率随时间增加。回肠造口术患者更频繁地出现高排出量、急性肾衰竭和与造口管理相关的并发症,住院时间也更长。然而,两组的医疗资源使用都很高,第一年住院天数中位数为13天,门诊就诊次数中位数为12次。每位患者的平均成本为20444.60英镑(26018.41美元);其中90.5%的成本归因于与造口相关的因素。
肠道造口形成后患者可能至少会经历一种临床并发症,并与NHS有多次互动。虽然回肠造口术患者中一些并发症更常见,但两组在手术后第一年与造口管理和恢复相关的费用都相当高。